Antiepoetin antibody-related pure red cell aplasia: Successful remission with cessation of recombinant erythropoietin alone

Clinical and Experimental Nephrology

Volumn 14, Issue 5, 2010, Pages 501-505

  Katagiri, Daisuke ^a   Shibata, Maki ^a   Katsuki, Takashi ^a   Masumoto, Shoichi ^a   Katsuma, Ai ^a   Minami, Eri ^a   Hoshino, Taro ^a   Inoue, Tsuyoshi ^a   Tada, Manami ^a   Hinoshita, Fumihiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Epoetin alfa; Epoetin beta; Pure red cell aplasia (PRCA); Renal anemia

Indexed keywords

ERYTHROPOIETIN ANTIBODY; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; DRUG WITHDRAWAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MALE; PURE RED CELL ANEMIA; REMISSION;

AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; EPOETIN ALFA; ERYTHROPOIETIN, RECOMBINANT; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; RED-CELL APLASIA, PURE;

EID: 78149416089     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0318-8     Document Type: Article

References (15)

1. N Casadevall J Nataf B Viron A Kolta JJ Kiladjian P Martin-Dupont, et al. 2002 Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin N Engl J Med 346 469 475 1:CAS:528:DC%2BD38XhtFCktr8%3D 10.1056/NEJMoa011931 11844847 (Pubitemid 34441737)
2. K Shinohara N Mitani M Miyazaki S Sakuragi K Matsuda S Ogawara, et al. 2005 Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure Am J Hematol 78 15 20 10.1002/ajh.20245 15609276 (Pubitemid 40023741)
3. G Weber J Gross A Kromminga HH Loew KU Eckardt 2002 Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins J Am Soc Nephrol 13 2381 2383 10.1097/01.ASN.0000027031.79843.6C 12191983 (Pubitemid 34925249)
4. SJ Swanson J Ferbas P Mayeux N Casadevall 2004 Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin Nephron Clin Pract 96 c88 c95 1:CAS:528:DC%2BD2cXivVKhsrc%3D 10.1159/000076746 15056991 (Pubitemid 38453092)
5. J Rossert 2005 Erythropoietin-induced, antibody-mediated pure red cell aplasia Eur J Clin Invest 35 Suppl 3 95 99 1:CAS:528:DC%2BD28XmsFeitQ%3D%3D 16281965 (Pubitemid 41783611)
6. D Verhelst J Rossert N Casadevall A Kruger KU Eckardt IC Macdougall 2004 Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study Lancet 363 1768 1771 1:CAS:528:DC%2BD2cXksVanu7g%3D 10.1016/S0140-6736(04) 16302-2 15172775 (Pubitemid 38698380)
7. CL Bennett D Cournoyer KR Carson J Rossert S Luminari AM Evens, et al. 2005 Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project Blood 106 3343 3347 1:CAS:528:DC%2BD2MXht1ehsb7O 10.1182/blood-2005-02- 0508 16099877 (Pubitemid 41609162)
8. P Fisch R Handgretinger HE Schaefer 2000 Pure red cell aplasia Br J Haematol 111 1010 1022 1:CAS:528:DC%2BD3MXhtVakurw%3D 10.1046/j.1365-2141.2000. 02429.x 11167735 (Pubitemid 32104912)
9. M Zecca P De Stefano B Nobili F Locatelli 2001 Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia Blood 97 3995 3997 1:CAS:528:DC%2BD3MXksVOqt74%3D 10.1182/blood.V97.12.3995 11389047
10. F Willis JC Marsh DH Bevan SB Killick G Lucas R Griffiths, et al. 2001 The effect of treatment with Campath-1H in patients with autoimmune cytopenias Br J Haematol 114 891 898 1:CAS:528:DC%2BD3MXnvVCgtL8%3D 10.1046/j.1365-2141. 2001.03039.x 11564082 (Pubitemid 32953751)
11. SS Prabhakar T Muhlfelder 1997 Antibodies to recombinant human erythropoietin causing pure red cell aplasia Clin Nephrol 47 331 335 1:STN:280:DyaK2szisFahug%3D%3D 9181281
12. N Casadevall E Dupuy P Molho-Sabatier G Tobelem B Varet P Mayeux 1996 Autoantibodies against erythropoietin in a patient with pure red-cell aplasia N Engl J Med 334 630 633 1:STN:280:DyaK287nt1yqsw%3D%3D 10.1056/ NEJM199603073341004 8592526 (Pubitemid 26072120)
13. B Viron CA Dupuy A Kolta N Casadevall 2008 Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs Nephrol Dial Transpl 23 2416 2418 10.1093/ndt/gfn051 (Pubitemid 351957609)
14. RB Stead J Lambert D Wessels JS Iwashita KK Leuther KW Woodburn 2006 Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers Blood 108 1830 1834 1:CAS:528:DC%2BD28Xpsl2is78%3D 10.1182/blood-2006-04-015818 16720830 (Pubitemid 44394989)
15. IC Macdougall J Rossert N Casadevall RB Stead AM Duliege M Froissart 2009 A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia N Engl J Med 361 1848 1855 1:CAS:528:DC%2BD1MXhtlyltbzK 10.1056/NEJMoa074037 19890127